The Canbex Therapeutics brand, founded in 2005 (United Kingdom), from 306 sister brands and 4958 competing brands. Canbex Therapeutics is a brand of Ipsen, listed on the stock exchange of Paris. The International Securities Identification Number (ISIN) of Ipsen is FR0010259150. Canbex Therapeutics is part of the Drug Manufacturers activity sector.